During the past decade, Yeungnam University College of Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yeungnam University College of Medicine" #1 collaborator was "Fresenius Medical Care North America" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Yeungnam University College of Medicine" are "Branch Retinal Vein Occlusion" (1 trials), "Central Serous Chorioretinopathy" (1 trials), "End-stage Renal Disease" (1 trials), "Epiretinal Membrane" (1 trials) and "Polypoidal Choroidal Vasculopathy" (1 trials). Many other conditions were trialed in "Yeungnam University College of Medicine" in a lesser frequency.

Most popular intervention types in "Yeungnam University College of Medicine" are "Procedure" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (1 trials), "Combined therapy group" (1 trials), "Indocyanine green angiography (intraveonus indocyanine green dye)" (1 trials), "Photodynamic therapy" (1 trials) and "Rituximab+mVPDL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yeungnam University College of Medicine" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Yeungnam University College of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Yeungnam University College of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yeungnam University College of Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".